Skip to content
OpenCapital
Get started

Eledon Pharmaceuticals, Inc. ELDN Q4 2025 Annual earnings

Reported March 19, 2026 · Before market open

EPS-$0.10Beat by $0.10
EPS estimate-$0.20

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.19

Versus estimates

Revenue

Q4 2024$192.0K

Diluted EPS

Q1 2026-$0.33Miss by $0.11
Q4 2025-$0.10Beat by $0.10
Q3 2025-$0.21Beat by $0.01Q2 2025-$0.13Beat by $0.10Q1 2025-$0.08Beat by $0.20Q4 2024-$0.64Miss by $0.32

Ask the moment Eledon Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eledon Pharmaceuticals, Inc. report Q4 2025 earnings?
Eledon Pharmaceuticals, Inc. (ELDN) reported Q4 2025 earnings on March 19, 2026 before market open.
What were Eledon Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
Eledon Pharmaceuticals, Inc. reported eps of $-0.10 for Q4 2025.
Did Eledon Pharmaceuticals, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.20 by $0.10.
How did Eledon Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 84.4% from $-0.64.
Where can I find Eledon Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-116154) and the 10-K periodic report (0001193125-26-116164) directly on SEC EDGAR. The filing index links above go to sec.gov.